Sponsor Pipeline

Thryv Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-23 NCT07277582
Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2)		 Trial sites expanded: 6 -> 9 locations
Active Trials by Phase
Phase 2/3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07277582 Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2) Long QT Syndrome (LQTS) 2 Recruiting
Not specified
NCT07075445 Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden… Long QT Syndrome Type 3 Recruiting
Get alerts when Thryv Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free